Eptifab 20mg/10ml (Eptifibatide Vials) 20mg/10ml

Eptifab 20mg/10ml is an injectable medication used to prevent blood clots in patients undergoing certain heart procedures. It belongs to the glycoprotein IIb/IIIa inhibitors class. Store between 2-8°C. Always consult a healthcare provider for proper use.

Strength

20mg/10ml

Pack Size

1's

Storage

2-8°

Manufacturer / TM Owner

Abbott Healthcare Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Eptifab 20mg/10ml is primarily used to reduce the risk of blood clots in patients with chest pain or those undergoing procedures like angioplasty or stent placement. It works by preventing platelets in the blood from sticking together. This medication is often prescribed for short-term use in hospital settings. It is not intended for long-term management of blood clots.

Side Effects

Eptifab 20mg/10ml may help maintain blood flow in coronary arteries during medical procedures. Patients may experience effects such as reduced chest pain or improved blood circulation. Some individuals might notice minor bruising or bleeding at the injection site. These effects are generally temporary and monitored by healthcare professionals.

Precautions & Warnings

Eptifab 20mg/10ml should be handled with care, as it can increase bleeding risk. Patients with a history of bleeding disorders or recent surgeries should inform their doctor before use. Keep the vial refrigerated between 2-8°C and protect it from light. Always follow medical guidance for administration and monitoring.

Avoid Interactions

Eptifab 20mg/10ml may interact with other blood thinners, NSAIDs, or medications affecting platelet function. Combining it with certain drugs could increase bleeding risk. Patients should disclose all medications, including over-the-counter and herbal products, to their healthcare provider. Alcohol and grapefruit may also pose risks when used with this medication.

References

Frequently Asked Questions

Eptifab 20mg/10ml is used to prevent blood clots in patients undergoing heart procedures like angioplasty.

It is given as an intravenous injection by a healthcare professional in a clinical setting.

Yes, it may increase bleeding risk, so careful monitoring is required during use.

Consult a doctor before use, as its safety during pregnancy has not been fully established.

Store the vial refrigerated between 2-8°C and protect it from light.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.